OSIRIS THERAPEUTICS INC NEW - COM (OSIR)

CUSIP: 68827R108

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
7,121,312
Share change
-180,907
Total reported value
$36,247,773
Put/Call ratio
133%
Price per share
$5.09
Number of holders
67
Value change
-$1,123,078
Number of buys
27
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 68827R108?
CUSIP 68827R108 identifies OSIR - OSIRIS THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSIRIS THERAPEUTICS INC NEW - COM (OSIR) as of Q2 2016

As of 30 Jun 2016, OSIRIS THERAPEUTICS INC NEW - COM (OSIR) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,121,312 shares. The largest 10 holders included FMR LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., STATE STREET CORP, NORTHERN TRUST CORP, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and QS Investors, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.